Title |
Liquid biomarkers in melanoma: detection and discovery
|
---|---|
Published in |
Molecular Cancer, January 2018
|
DOI | 10.1186/s12943-018-0757-5 |
Pubmed ID | |
Authors |
Su Yin Lim, Jenny H. Lee, Russell J. Diefenbach, Richard F. Kefford, Helen Rizos |
Abstract |
A vast array of tumor-derived genetic, proteomic and cellular components are constantly released into the circulation of cancer patients. These molecules including circulating tumor DNA and RNA, proteins, tumor and immune cells are emerging as convenient and accurate liquid biomarkers of cancer. Circulating cancer biomarkers provide invaluable information on cancer detection and diagnosis, prognosticate patient outcomes, and predict treatment response. In this era of effective molecular targeted treatments and immunotherapies, there is now an urgent need to implement use of these circulating biomarkers in the clinic to facilitate personalized therapy. In this review, we present recent findings in circulating melanoma biomarkers, examine the challenges and promise of evolving technologies used for liquid biomarker discovery, and discuss future directions and perspectives in melanoma biomarker research. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 20% |
United States | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 161 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 25 | 16% |
Student > Ph. D. Student | 23 | 14% |
Student > Master | 21 | 13% |
Student > Bachelor | 19 | 12% |
Other | 11 | 7% |
Other | 22 | 14% |
Unknown | 40 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 35 | 22% |
Medicine and Dentistry | 32 | 20% |
Agricultural and Biological Sciences | 14 | 9% |
Chemistry | 7 | 4% |
Engineering | 5 | 3% |
Other | 24 | 15% |
Unknown | 44 | 27% |